Inari Medical, Inc. (NARI) |
| 79.97 0 (0%) 02-18 16:00 |
| Open: | 79.96 |
| High: | 79.97 |
| Low: | 79.96 |
| Volume: | 2,356,692 |
| Market Cap: | 4,683(M) |
| PE Ratio: | -59.24 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 13.07 |
| Resistance 1: | 11.19 |
| Pivot price: | 10.93 |
| Support 1: | 10.84 |
| Support 2: | 10.62 |
| 52w High: | 79.99 |
| 52w Low: | 36.73 |
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
| EPS | 0.810 |
| Book Value | 13.250 |
| PEG Ratio | 1.33 |
| Gross Profit | 1.399 |
| Profit Margin (%) | 47.29 |
| Operating Margin (%) | 41.43 |
| Return on Assets (ttm) | 1.4 |
| Return on Equity (ttm) | 6.9 |
Sun, 17 May 2026
Inari Medical stock (US45332Y1092): earnings jump and new clot-treatment data keep focus on growth - AD HOC NEWS
Sat, 16 May 2026
Inari Medical stock (US45332Y1092): Stryker deal reshapes outlook for thrombectomy specialist - AD HOC NEWS
Thu, 14 May 2026
Inari Medical stock (US45332Y1092): Recent trading activity shows stability around $80 - AD HOC NEWS
Wed, 19 Feb 2025
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment - GlobeNewswire
Wed, 19 Feb 2025
Inari Medical, Inc. (NARI): the Best Performing Healthcare Stock So Far in 2025 - Yahoo Finance
Sat, 15 Feb 2025
Stryker Acquires Inari Medical: A $4.7 Billion Healthcare Merger (SYK, NARI) - tradingcalendar.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |